Cytosine arabinoside therapy for Herpes Zoster in a patient with systemic lupus erythematosus.
D000293:Adolescent; D002699:Chlorambucil / Q000009:adverse effects; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects; D014276:Trigeminal Nerve
D007166:Immunosuppressive Agents; D003561:Cytarabine; D002699:Chlorambucil; D011241:Prednisone